ACET

Adicet Bio
ACET

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$50.43M
EV
$-83.76M
Shares Outstanding
82.69M
Beta
1.65

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$6.40
P/E 2025E
-
P/Revenue 2025E
10.46x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Adicet Bio, Inc.

gainify
ACET

Adicet Bio, Inc.

ACET

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable ...

Sector

Healthcare

Industry

Biotechnology

CEO

Schor, Chen

Employees

152

IPO Date

2018-01-26

Headquarters

131 Dartmouth Street, 3rd Floor, Boston, Massachusetts, 02116, United States

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.